These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5328496)

  • 1. Bilivistan, a new contrast medium for I. V. cholegraphy.
    Egeblad M
    Dan Med Bull; 1966 May; 13(2):36-40. PubMed ID: 5328496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of Bilivistan, a new contrast medium for cholecystography].
    Bång I
    Nord Med; 1967 Jul; 78(30):970-1. PubMed ID: 5339533
    [No Abstract]   [Full Text] [Related]  

  • 3. Ioglycamide (Bilivistan) as a contrast medium for intravenous cholegraphy. A clinical and experimental investigation.
    Brismar J; Lindgren P; Saltzman GF
    Acta Radiol Diagn (Stockh); 1971 Mar; 11(2):129-47. PubMed ID: 4931558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on possible cardio-circulatory repercussions during intramuscular colangiocholecystography by means of a new hexaiodinated contrast medium].
    Strozzi C; Biolcati-Rinaldi A
    Arch Ital Mal Appar Dig; 1968; 35(3):271-302. PubMed ID: 5733150
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new contrast medium for oral cholecystography].
    Sapounov S
    Rontgenpraxis; 1973 Sep; 26(9):203-7. PubMed ID: 4763497
    [No Abstract]   [Full Text] [Related]  

  • 6. The side-effects of Bilivistan compared to those of Biligrafine forte.
    Kastelein A; de Planque BA
    Radiol Clin Biol; 1968; 37(2):113-8. PubMed ID: 5674729
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new contrast medium for cholecystography: iopronic acid (B 11420)].
    Macchi C; Fiore D; Corbetti F
    Radiol Med; 1978 Nov; 64(11):1217-22. PubMed ID: 740932
    [No Abstract]   [Full Text] [Related]  

  • 8. [The protective effects of corticosteroid agent on the side effects of intravenous cholecystography (author's transl)].
    Ohshima T; Mio A; Tsukiyama I
    Rinsho Hoshasen; 1979 Aug; 24(8):831-7. PubMed ID: 529462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cholangio-cholecystography using Bilivistan, a new transvenous contrast medium].
    Shirakabe H; Ueno T; Ofuji M; Kohakuki S; Kuroda K
    Rinsho Hoshasen; 1966 Jan; 11(1):30-6. PubMed ID: 5181030
    [No Abstract]   [Full Text] [Related]  

  • 10. [A modification of the method of intravenous cholegraphy. (Radiography 24 hours after administration of the contrast medium)].
    Ioffe VS
    Klin Med (Mosk); 1966 Apr; 44(4):77-80. PubMed ID: 5987727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of ceruletide in cholecystography].
    Orzechowska R; Baron J
    Pol Tyg Lek; 1981 Oct; 36(40):1549-51. PubMed ID: 7038641
    [No Abstract]   [Full Text] [Related]  

  • 12. [First comparative radiologic studies between "bilivistan" (a new contrast media for cholangio-cholecystography) and "biligrafin"].
    Miceli R
    Ann Radiol Diagn (Bologna); 1965; 38(3):239-65. PubMed ID: 5864226
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bilimiro (B 11.420) "Bracco"--a new hepatotropic contrast medium for oral cholecystography].
    Lazecki L
    Pol Przegl Radiol Med Nukl; 1973; 37(4):509-11. PubMed ID: 4754004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood circulation reactions following injection of x-ray contrast media].
    Maurer HJ; Hahn N
    Z Kreislaufforsch; 1967 Oct; 56(10):993-1002. PubMed ID: 5592254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does oral and intravenous "refill" cholegraphy have nephrotoxic effects?].
    Bor K; Elek S; Elekes I; Polgári I; Csákány G
    Orv Hetil; 1984 Apr; 125(14):815-9. PubMed ID: 6709344
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comment on the article by Taenzer, V., et al.: Intravenous cholegraphy with Chologram(R), Fortschr. Röntgenstr. 123 (1975) 414].
    Kölling K
    Rofo; 1976 Apr; 124(4):328-9. PubMed ID: 131757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heterotopic contrast media excretion: excretion of bilivistan through the mucous membrane of the stomach and small intestine].
    Reinhardt K
    Fortschr Geb Rontgenstr Nuklearmed; 1967 Feb; 106(2):288-91. PubMed ID: 5626687
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast medium tolerance in computed tomography.
    Tschakert H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():156-61. PubMed ID: 6139072
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative trial of oral cholecystographic contrast agents.
    Wall JJ
    Radiography; 1972 Jul; 38(451):180-4. PubMed ID: 5070481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse effects of a new non-ionic contrast medium in heart catheterization].
    Meyer GP; Trappe HJ; Jost S; Rafflenbeul W; Wenzlaff P; Lichtlen P
    Arzneimittelforschung; 1993 Aug; 43(8):932-4. PubMed ID: 8216457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.